We are live on ! Find out more
PWM

Palumbo Wealth Management Portfolio holdings

AUM $410M
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+32.56%
3 Year Est. Return
+80.66%
5 Year Est. Return
+99.66%
10 Year Est. Return
AUM
$237M
AUM Growth
+$13.3M
Cap. Flow
+$10.5M
Cap. Flow %
4.42%
Top 10 Hldgs %
41.74%
Holding
157
New
17
Increased
80
Reduced
45
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 13.66%
2 Consumer Discretionary 6.48%
3 Financials 6.3%
4 Healthcare 6.02%
5 Consumer Staples 5.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTNX icon
126
Nutanix
NTNX
$16B
$216K 0.09%
+3,796
New +$233K
ASRT
127
DELISTED
Assertio
ASRT
$211K 0.09%
11,340
+1,765
+18% +$26.2K
VZ icon
128
Verizon
VZ
$195B
$205K 0.09%
4,972
-27
-0.5% -$1.09K
NET icon
129
Cloudflare
NET
$99B
$202K 0.09%
+2,435
New +$196K
T icon
130
AT&T
T
$159B
$198K 0.08%
10,361
+155
+2% +$2.69K
ABR icon
131
Arbor Realty Trust
ABR
$964M
$195K 0.08%
13,613
+424
+3% +$5.67K
SEER icon
132
Seer Inc
SEER
$122M
$179K 0.08%
106,291
+13,070
+14% +$24.4K
ARDX icon
133
Ardelyx
ARDX
$1.22B
$174K 0.07%
+23,549
New +$166K
ERAS icon
134
Erasca
ERAS
$6.3B
$161K 0.07%
68,345
-10,091
-13% -$21.8K
OPTN
135
DELISTED
OptiNose
OPTN
$141K 0.06%
9,035
+1,100
+14% +$18.4K
INFN
136
DELISTED
Infinera Corporation Common Stock
INFN
$135K 0.06%
22,104
+4,824
+28% +$25.5K
XGN icon
137
Exagen
XGN
$109M
$121K 0.05%
66,669
+48,428
+265% +$82K
DSGN icon
138
Design Therapeutics
DSGN
$761M
$111K 0.05%
33,054
+16,082
+95% +$62.7K
ZUO
139
DELISTED
Zuora, Inc.
ZUO
$103K 0.04%
+10,326
New +$99.3K
OCUL icon
140
Ocular Therapeutix
OCUL
$1.79B
$86.6K 0.04%
+12,667
New +$78.2K
NUVB icon
141
Nuvation Bio
NUVB
$2.2B
$82.8K 0.04%
28,350
+8,281
+41% +$25.3K
OABI icon
142
OmniAb
OABI
$287M
$82.1K 0.03%
21,896
+8,076
+58% +$36.8K
MTTR
143
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$66.4K 0.03%
14,861
+905
+6% +$3.43K
ACHR icon
144
Archer Aviation
ACHR
$3.54B
$64.5K 0.03%
18,316
+5,329
+41% +$19.8K
ZVRA icon
145
Zevra Therapeutics
ZVRA
$562M
$63.2K 0.03%
12,902
-5,186
-29% -$24.6K
INZY
146
DELISTED
Inozyme Pharma
INZY
$60.6K 0.03%
+13,584
New +$65.9K
ADCT icon
147
ADC Therapeutics
ADCT
$134M
$41.9K 0.02%
+13,270
New +$52.7K
NAUT icon
148
Nautilus Biotechnolgy
NAUT
$124M
$41.6K 0.02%
+17,793
New +$46.5K
SIRI icon
149
SiriusXM
SIRI
$9.98B
$31.7K 0.01%
1,119
-14
-1% -$418
ELEV
150
DELISTED
Elevation Oncology
ELEV
$30.4K 0.01%
11,266
-6,477
-37% -$24.4K

Similar funds

Palumbo Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, Palumbo Wealth Management held 157 positions worth $237M, up 6% from $223M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Palumbo Wealth Management deployed $10.5M of net new capital in Q2 2024, opening 17 new positions and adding to 80 existing holdings. Its largest new stake was Entergy: 45,522 shares worth $2.44M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.58M trimmed.

  • Palumbo Wealth Management's largest Q2 2024 buy was Entergy: 45,522 shares worth $2.44M.
  • Palumbo Wealth Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2024, an estimated $2.72M increase.
  • Palumbo Wealth Management's biggest Q2 2024 reduction was SPDR Gold Trust, cutting an estimated $1.58M.
  • Palumbo Wealth Management fully exited Brown-Forman Class B in Q2 2024, selling an estimated $1.62M.
  • Palumbo Wealth Management's ten largest holdings make up 42% of its $237M portfolio in Q2 2024.
  • Palumbo Wealth Management opened 17 new positions and closed 6 in Q2 2024.
  • Palumbo Wealth Management's portfolio value rose 6% quarter-over-quarter to $237M.

Based on Palumbo Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.